Loading clinical trials...
Loading clinical trials...
EnBrace HR for Premenstrual Syndrome (PMS) With Prominent Mood Symptoms (or Menstrual Related Mood Disorders, MRMD)
Conditions
Interventions
EnBrace HR Softgel
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
November 1, 2019
Primary Completion Date
November 1, 2021
Completion Date
November 1, 2022
Last Updated
January 2, 2020
NCT06724419
NCT06704594
NCT06648382
NCT07013539
NCT07461051
NCT07074314
Lead Sponsor
Massachusetts General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions